A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors.
A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors.
复制标题
DOI:
10.1158/0008-5472.can-10-0607
复制
发表时间:
2010-09-15
期刊:
影响因子:
11.2
通讯作者:
Druker BJ
中科院分区:
文献类型:
--
作者:
Seo JH;Wood LJ;Agarwal A;O'Hare T;Elsea CR;Griswold IJ;Deininger MW;Imamoto A;Druker BJ
CRKL (CRK-Like) is an adapter protein predominantly phosphorylated in cells that express the tyrosine kinase p210BCR-ABL, the fusion product of a (9;22) chromosomal translocation causative for chronic myeloid leukemia (CML). It has been unclear, however, whether CRKL plays a functional role in p210BCR-ABL transformation. Here we show that CRKL is required for p210BCR-ABL to support IL-3-independent growth of myeloid progenitor cells and long-term outgrowth of B-lymphoid cells from fetal liver-derived hematopoietic progenitor cells. Furthermore, a synthetic phosphotyrosyl peptide that binds to the CRKL SH2 domain with high affinity blocks association of endogenous CRKL with the p210BCR-ABL complex and reduces c-MYC levels in K562 human leukemic cells as well as mouse hematopoietic cells transformed by p210BCR-ABL or the imatinib-resistant mutant T315I. These results indicate that the function of CRKL as an adapter protein is essential for p210BCR-ABL-induced transformation.